CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
(MMR) system, that fixes genetic mistakes. In most endometrial cancers, this system works normally, and these cancers are ...
Phase 3
White Plains, New York, United States and 53 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Stony Brook, New York, United States and 318 other locations
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
New Haven, Connecticut, United States and 29 other locations
The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial...
Phase 2
New Haven, Connecticut, United States
This study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial c...
Phase 2
Commack, New York, United States and 6 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
New Haven, Connecticut, United States and 243 other locations
The researchers are doing this study to find out if ivonescimab is an effective treatment for people with endometrial cancer (EC) a...
Phase 2
Commack, New York, United States and 6 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
West Islip, New York, United States and 83 other locations
The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth f...
Phase 3
New Haven, Connecticut, United States and 205 other locations
standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...
Phase 3
Danbury, Connecticut, United States and 179 other locations
Clinical trials
Research sites
Resources
Legal